Development of a sheep model of atrial fibrillation for preclinical prosthetic valve testing

Journal of Heart Valve Disease

Volumn 16, Issue 3, 2007, Pages 314-323

  Rivard, Andrew L ^a,b   Suwan, Phillip T ^a   Imaninaini, Keyoumars ^a   Gallegos, Robert P ^c   Bianco, Richard W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOXYCYCLINE; ISOPRENALINE; PROPRANOLOL;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL STUDY; EXPERIMENTAL MODEL; GENE TRANSFER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PROARRHYTHMIA; HEART VALVE PROSTHESIS; INCIDENCE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SAMPLE SIZE; SHEEP DISEASE; SINUS RHYTHM; STEM CELL TRANSPLANTATION; SURGICAL APPROACH; SURGICAL RISK; THROMBOEMBOLISM;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CHOLINERGIC AGENTS; HEART VALVE PROSTHESIS; MATERIALS TESTING; MODELS, ANIMAL; MODELS, GENETIC; SHEEP; STEM CELL TRANSPLANTATION; THROMBOEMBOLISM;

EID: 34250004281     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Replacement Heart Valve Guidance (draft document). 1994, US Department of Health and Human Services, p. 56
2. Edmunds LH, Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987;44:430-445
3. Gregoric ID, Eya K, Tamez D, et al. Preclinical hemodynamic assessment of a new trileaflet mechanical valve in the aortic position in a bovine model. J Heart Valve Dis 2004;13:254-259
4. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001;104(12 Suppl.1):I59-I63
5. Kuntze CE, Blackstone EH, Ebels T. Thromboembolism and mechanical heart valves: A randomized study revisited. Ann Thorac Surg 1998;66:101-107
6. Kernis SJ, Nkomo VT, Messika-Zeitoun D, et al. Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm: Incidence, outcome, and determinants. Circulation 2004;110:2320-2325
7. Cayly M, Kanadasi M, Demir M, Acarturk E. Mitral annular systolic velocity reflects the left atrial appendage function in mitral stenosis. Echocardiography 2006;23:546-552
8. Benussi S, Verzini A, Alfieri O. Mitral valve replacement and thromboembolic risk. J Heart Valve Dis 2004;13(Suppl.1):S81-S83
9. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641
10. Iqbal MB, Taneja AK, Lip GY, Flather M. Recent developments in atrial fibrillation. Br Med J 2005;330:238-243
11. Tsang TS, Petty GW, Barnes ME, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: Changes over three decades. J Am Coll Cardiol 2003;42:93-100
12. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S, Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002;106:75-80
13. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997;336:1429-1434
14. Obadia JF, el Farra M, Bastien OH, et al. Outcome of atrial fibrillation after mitral valve repair. J Thorac Cardiovasc Surg 1997;114:179-185
15. Gallegos RP, Nockel PJ, Rivard AL, Bianco RW. The current state of in-vivo pre-clinical animal models for heart valve evaluation. J Heart Valve Dis 2005;14:423-432
16. Medical devices - Application of risk management to medical devices. Association for the Advancement of Medical Instrumentation, 2000, p. 27
17. Bodnar E. The Medtronic Parallel valve and the lessons learned. J Heart Valve Dis 1996;5:572-573
18. Shimizu A, Centurion OA. Electrophysiological properties of the human atrium in atrial fibrillation. Cardiovasc Res 2002;54:302-314
19. Pandozi C, Santini M. Update on atrial remodelling owing to rate: Does atrial fibrillation always 'beget' atrial fibrillation? Eur Heart J 2001;22:541-553
20. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968
21. Kamalvand K, Tan K, Lloyd G, et al. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man. Eur Heart J 1999;20:888-895
22. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246
23. Vidne B, Erdman S, Levy MJ. Thromboembolism following heart valve replacement by prosthesis: Survey among 365 consecutive patients. Chest 1973;63:713-717
24. Sakashita I, Ohtani S, Nakamura C, Washio M, Clinical evaluation of a new anticoagulant therapy in prosthetic valve replacement. Jpn Heart J 1978;19:324-331
25. Stanford W, Lindberg EF, Armstrong RG. Implantation of heart valve prostheses without anticoagulants. J Thorac Cardiovasc Surg 1972;63:648-651
26. Willems R, Ector H, Holemans P, Van De Werf F, Heidbuchel H. Effect of different pacing protocols on the induction of atrial fibrillation in a transvenously paced sheep model. Pacing Clin Electrophysiol 2001;24:925-932
27. Willems R, Holemans P, Ector H, et al. Mind the model: Effect of instrumentation on inducibility of atrial fibrillation in a sheep model. J Cardiovasc Electrophysiol 2002;13:62-67
28. Yu WC, Chen SA, Lee SH, et al. Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiar-rhythmic drugs. Circulation 1998;97:2331-2337
29. Goldberg L, Hagies P, Grigorov V. Transoesophageal atrial pacing stress echocardiography in coronary artery disease: Role, principles and methodology. Cardiovasc J S Afr 2004;15:81-87
30. Kohl TKP, Gogarten W, Reckers J, et al. Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: A minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses. Circulation 1999;100:772-776
31. Schrickel JW, Bielik H, Yang A, et al. Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol 2002;97:452-460
32. Au-Yeung K, Johnson CR, Wolf PD. A novel implantable cardiac telemetry system for studying atrial fibrillation. Physiol Meas 2004;25:1223-1238
33. Garratt CJ, Duytschaever M, Killian M, et al. Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: No cumulative effect on inducibility or stability of atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:1101-1108
34. Todd DM, Fynn SP, Hobbs WJ, Fitzpatrick AP, Garratt CJ. Prevalence and significance of focal sources of atrial arrhythmia in patients undergoing cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:616-622
35. Everett TH, Li H, Mangrum JM, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-1460
36. Chen ZJ, Kren BT, Wong PY, Low WC, Steer CJ. Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference. Biochem Biophys Res Commun 2005;329:646-652
37. Sharifov OF, Fedorov VV, Beloshapko GG, et al. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol 2004;43:483-490
38. Cox JL, Schuessler RB, D'Agostino HJ, Jr., et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583
39. Sharifov OF, Zaitsev AV, Rosenshtraukh LV, et al. Spatial distribution and frequency dependence of arrhythmogenic vagal effects in canine atria. J Cardiovasc Electrophysiol 2000;11:1029-1042
40. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, et al. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 1998;81:1207-1210
41. Burashnikov A, Antzelevitch C. Block of I(Ks) does not induce early afterdepolarization activity but promotes beta-adrenergic agonist-induced delayed afterdepolarization activity. J Cardiovasc Electrophysiol 2000;11:458-465
42. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-786
43. Inoue H, Zipes DP. Changes in atrial and ventricular refractoriness and in atrioventricular nodal conduction produced by combinations of vagal and sympathetic stimulation that result in a constant spontaneous sinus cycle length. Circ Res 1987;60:942-951
44. Sharifov OF, Rozenshtraukh LV, Zaitsev AV, et al. Comparison of atrial premature depolarization topography during vagal stimulation and humoral acetylcholine administration. Ross Fiziol Zh Im I M Sechenova 1998;84:1174-1190
45. Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163
46. Lai LP, Lin JL, Huang SK. Molecular genetic studies in atrial fibrillation. Cardiology 2003;100:109-113
47. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911
48. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254
49. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447-454
50. Tsai CT, Lai LP, Lin JL, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-1646
51. Zhang YM, Hartzell C, Narlow M, Dudley SC, Jr. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 2002;106:1294-1299
52. Raman SV, Cooke GE, Binkley PF. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 2003;107:e195; author reply e195
53. Rosen MR, Brink PR, Cohen IS, Robinson RB. Genes, stem cells and biological pacemakers. Cardiovasc Res 2004;64:12-23
54. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083
55. Mocini D, Colivicchi F, Santini M. Stem cell therapy for cardiac arrhythmias. Ital Heart J 2005;6:267-271
56. Claycomb WC, Lanson NA, Jr., Stallworth BS, et al. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95:2979-2984
57. Lamartina S, Roscilli G, Rinaudo CD, et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 2002;13:199-210
58. Ruhparwar A, Tebbenjohanns J, Niehaus M, et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg 2002;21:853-857
59. Cox JL. Atrial fibrillation I: A new classification system. J Thorac Cardiovasc Surg 2003;126:1686-1692